CompaniesImcyse

Imcyse

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

6

As Collaborator

1

Total Enrollment

7,348

By Phase

PHASE1/PHASE2: 2PHASE2: 1NA: 1PHASE1: 2

By Status

COMPLETED: 3TERMINATED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04629274
NCT04524949
NCT05417269
NCT06280755
Hover over trial bars to see details

Recent Trials

NCT06280755Collaborator
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
N/ARecruiting
7,000 participants
Started: Mar 1, 2024 · Completed: Apr 30, 2027
NCT05417269Lead Sponsor
IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study
PHASE1/PHASE2Active, not recruiting
150 participants
Started: Apr 12, 2022 · Completed: Dec 31, 2025
NCT04524949Lead Sponsor
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
PHASE2Terminated
110 participants
Started: Dec 29, 2020 · Completed: May 29, 2024
NCT04629274Lead Sponsor
In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO
NACompleted
15 participants
Started: Jun 15, 2020 · Completed: Jun 3, 2024
NCT04190693Lead Sponsor
IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
PHASE1Completed
30 participants
Started: Feb 14, 2019 · Completed: Nov 18, 2019
View all 7 trials →